Sensus Healthcare, Inc.

Sensus Healthcare reported a net loss of $7.7 million for FY 2025, a significant decline from a net income of $6.6 million in FY 2024. Revenue decreased 34% to $27.5 million, primarily due to a lower number of units sold (70 vs. 115) and reduced sales to its largest customer. Gross profit fell 51% to $11.9 million, with gross margin contracting from 58.4% to 43.3% due to higher servicing costs and expenses from new placements under the Fair Deal Agreement. Operating expenses increased 36% to $22.2 million, driven by higher research and development costs (up 86% to $7.8 million) for lobbying activities and product development. The company generated positive operating cash flow of $0.5 million and ended the year with $22.1 million in cash. Management expects lower R&D expenses in 2026 and anticipates increased demand from new CMS reimbursement codes effective January 1, 2026.

Key Takeaways